Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of LuAA21004 on Cognitive Dysfunction in Major Depressive Disorder
This study is currently recruiting participants.
Verified January 2013 by Takeda Global Research & Development Center, Inc.
Study NCT01564862   Information provided by Takeda Global Research & Development Center, Inc.

First Received on March 26, 2012.   Last Updated on January 17, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depressive Disorder, Major
Additional conditions recognized in this trial
Cognition Disorders
Depression
Depressive Disorder
More general conditions related to this trial
Behavioral Symptoms
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Mood Disorders
Interventions listed in this trial
LuAA21004
Duloxetine
Placebo
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Antidepressive Agents
Central Nervous System Agents
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Takeda Global Research & Development Center, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services